CBD is everywhere! From chocolate shops to gummy bears, CBD infused salad to CBD infused beer, and now a company is launching non-alcoholic shots with CBD.
CBD has sprawled across the entire globe, let alone different countries and companies are leaving no chance of taking advantage of it. The compound is basically a hemp-derived formula which has anti-inflammatory properties and is non-psychoactive in nature.
This means that CBD does not produce any mind-altering effects which lead to hallucinations or the ‘high’ that people experience while smoking weed or marijuana. The compound responsible for causing the ‘high’ is known as THC or tetrahydro cannabinoid which has been restricted by all law enforcement bodies. THC is highly dangerous for consumption and if used in high potency for a long period of time, it leads to permanent mental disorders.
CBD has been associated with plenty of medical benefits. It is widely popular to treat stress, depression, anxiety, panic attacks and severe mental health disorders such as epilepsy and Alzheimer’s. People have also been relying on CBD for their daily needs like acute pain, aches, inflammation, swelling, recovery from an accident and even Cancer sometimes.
But the lack of evidence and scientific proof is what worries governments and law enforcement officials all around the world. From the United States Food and Drug Administration to the government of the United Kingdom, all the countries on the verge of legalizing CBD or already dealing with it seems to be tensed about public safety.
Though there are some studies that suggest how effective CBD is and how it can work as an alternative for opioids, there’s hardly any internationally recognized study or research which supports the claims of CBD.
A company in the United Kingdom has launched non-alcoholic shots with CBD in 3 different flavors: ‘Zest’, which is marketed as a product to improve heart health and low blood pressure; ‘Spice’, which is marketed as a product that helps to increase concentration and ‘Bloom’, which OTO claims is a product that will help in improving the quality of sleep and reduce anxiety.
Each shot of 60ml contains 50mg of “high-quality” CBD. Each shot is priced at £6.99. The company already sells a wide variety of “high-strength” CBD-infused cocktail bitters.
As per the figures from the Cannabis Trades Association United Kingdom, the number of cannabidiol users has almost doubled from 125,000 in 2017 to nearly 250,000 in 2018.
The range of drinks has been curated by a team of industry leaders including Antonia Jamison, a founding director at the Sipsmith Gin, Dr. Ketan Joshi, food scientist, Gemma Calao, managing director of OTO and James Bagley, CEO of DMD Ventures, which is the owner of drinks retailer 31 Dover.
The CBD for the shots is derived from organically grown hemp plants, while each of the flavors is infused with botanicals handpicked to complement the effects of cannabidiol such as ginger, turmeric, lavender, cinnamon, and lemongrass.
Gemma Colao, co-creator said that the new RTDs are an elegant and simple way to enjoy the perfect dose of CBD, whether it is consumed in a shot or mixed with a cocktail. Gemma further stated that they have created 3 unique blends which perfectly complement the needs of their customer’s, from improving their health to creating a balance in their everyday lives.
Joshi added that the company has carried out intensive research and trials to evaluate the right dosage and determine the optimum daily dose of cannabidiol. Their continuous trials have proven amazing medical benefits of CBD, with users experiencing fantastic benefits from increased focus, better sleep to reduced anxiety.
The company seems to be confident about their product and says that their new RTDs will prompt more people to incorporate CBD into their daily routines in a simple and effective manner- and enjoy the benefits of improved health and wellbeing overall.
The shots are now available on both off-trade and on-trade from the OTO’s website.